Showing results (131-140 of 553) with videos related to
Sort By:
Pageof 56
Drugs in Context|June 20, 2022
Dermatology: how to manage facial hyperpigmentation in skin of colourSiddiq Moolla, Yvette Miller-MonthropeDrugs in Context|August 16, 2014
One-year prevalence, comorbidities and cost of cachexia-related inpatient admissions in the USASusan Tsivitse Arthur, Joshua M Noone, Bryce A Van Doren, et al.Drugs in Context|April 27, 2016
Inpatient resource use and costs associated with switching from oral antipsychotics to aripiprazole once-monthly for the treatment of schizophreniaMichele Wilson, Benjamin Gutierrez, Steve J Offord, et al.Drugs in Context|July 13, 2016
Efficacy of telbivudine with conditional tenofovir intensification in patients with chronic hepatitis B: results from the 2-year roadmap strategyTeerha Piratvisuth, Piyawat Komolmit, Henry Ly Chan, et al.Drugs in Context|July 13, 2016
Anticoagulation for the prevention of stroke in non-valvular AF in general practice: room for improvementAdam Ioannou, Sofia Metaxa, George Kassianos, et al.Drugs in Context|September 27, 2019
Hemorrhoid management in women: the role of tribenoside + lidocaineJan KestřánekDrugs in Context|October 7, 2016
Pharmacoeconomic comparison of aripiprazole once-monthly and paliperidone palmitate from a head-to-head clinical trial in schizophrenia: a US analysisChristophe Sapin, Ann Hartry, Siddhesh A Kamat, et al.Drugs in Context|February 19, 2019
Medication adherence and treatment-resistant hypertension: a reviewMohammed Awais Hameed, Indranil DasguptaDrugs in Context|March 1, 2021
The race to a COVID-19 vaccine: opportunities and challenges in development and distributionRodrigo M Burgos, Melissa E Badowski, Emily Drwiega, et al.Drugs in Context|May 5, 2025
Switching from multiple-inhaler triple therapy to single, extrafine-inhaler triple therapy in severe refractory asthma with EGPA: beyond control. Case report and review of the literatureFrancesco Menzella, Marcello Cottini, Silvia Tonin, et al.Pageof 56